P/E ratio for Soligenix (SNGX)
P/E ratio as of April 2024 (TTM): -0.1592
According to Soligenix's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.159195. At the end of 2022 the company had a P/E ratio of -1.52.
P/E ratio history for Soligenix from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.52 | -35.02% |
| 2021 | -2.35 | 22.77% |
| 2020 | -1.91 | -35.44% |
| 2019 | -2.96 | 154.63% |
| 2018 | -1.16 | -38.75% |
| 2017 | -1.90 | -22.42% |
| 2016 | -2.45 | -33.12% |
| 2015 | -3.66 | 19.41% |
| 2014 | -3.06 | 0.38% |
| 2013 | -3.05 | 88.14% |
| 2012 | -1.62 | -37.84% |
| 2011 | -2.61 | -49.89% |
| 2010 | -5.21 | -16.71% |
| 2009 | -6.25 | 108.33% |
| 2008 | -3.00 | 23.53% |
| 2007 | -2.43 | 31.55% |
| 2006 | -1.85 | -45.3% |
| 2005 | -3.38 | -10.35% |
| 2004 | -3.76 | 6.18% |
| 2003 | -3.55 | 118.76% |
| 2002 | -1.62 | 87.24% |
| 2001 | -0.8655 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.4 | -6,616.91% | 🇺🇸 USA |
 Pfizer PFE | 13.7 | -8,674.70% | 🇺🇸 USA |
 Sanofi SNY | 15.5 | -9,818.96% | 🇫🇷 France |
 Onconova Therapeutics ONTX | -0.9953 | 525.21% | 🇺🇸 USA |
 Athersys ATHX | -0.0045 | -97.20% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -6.91 | 4,237.45% | 🇮🇱 Israel |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -0.1589 | -0.16% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.